Acet, HalitGüzel, TuncayAslan, BayramIşık, Mehmet AliErtaş, FarukÇatalkaya, Sibel2022-05-242022-05-242021Acet, H., Güzel, T., Aslan, B., Işık, M.A., Ertaş, F. ve Çatalkaya, S. (2021). Predictive value of C-reactive protein to albumin ratio in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. Angiology, 72(3), 244-251.0003-31971940-1574https://hdl.handle.net/11468/9884WOS:000614539900006PMID: 33371718The present study aimed to examine the association of C-reactive protein to albumin ratio (CAR) with short-term major adverse cardiac events (MACEs) in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI). We included 539 STEMI patient treated with pPCI in this study. Patients were divided into 2 groups according to MACE development. Patients with MACE had higher CAR than those without (1.18 [0.29-1.99] vs 0.21 [0.09-0.49], P < .001). Multivariate analysis showed that The Global Record for Acute Coronary Events score, Percutaneous Coronary Intervention with TAXus and cardiac surgery (SYNTAX) score, glucose and CAR (odds ratio:1.326, 95% CI: 1.212-1452, P < .001) were independent predictors of MACE. The CAR may be proven useful for risk stratification in STEMI patients undergoing pPCIeninfo:eu-repo/semantics/closedAccessST-segment elevation myocardial infarctionMajor adverse cardiac eventsC-reactive protein to albumin ratioArticle723244251WOS:0006145399000062-s2.0-850984970703337171810.1177/0003319720963697Q2Q3